222 related articles for article (PubMed ID: 37287056)
1. Significant improvement of bone marrow-derived MSC expansion from MDS patients by defined xeno-free medium.
Altrock E; Sens-Albert C; Hofmann F; Riabov V; Schmitt N; Xu Q; Jann JC; Rapp F; Steiner L; Streuer A; Nowak V; Obländer J; Weimer N; Palme I; Göl M; Darwich A; Wuchter P; Metzgeroth G; Jawhar M; Hofmann WK; Nowak D
Stem Cell Res Ther; 2023 Jun; 14(1):156. PubMed ID: 37287056
[TBL] [Abstract][Full Text] [Related]
2. Defined serum-free media for in vitro expansion of adipose-derived mesenchymal stem cells.
Al-Saqi SH; Saliem M; Asikainen S; Quezada HC; Ekblad A; Hovatta O; Le Blanc K; Jonasson AF; Götherström C
Cytotherapy; 2014 Jul; 16(7):915-26. PubMed ID: 24726655
[TBL] [Abstract][Full Text] [Related]
3. Isolation method and xeno-free culture conditions influence multipotent differentiation capacity of human Wharton's jelly-derived mesenchymal stem cells.
Corotchi MC; Popa MA; Remes A; Sima LE; Gussi I; Lupu Plesu M
Stem Cell Res Ther; 2013 Jul; 4(4):81. PubMed ID: 23845279
[TBL] [Abstract][Full Text] [Related]
4. Are serum-free and xeno-free culture conditions ideal for large scale clinical grade expansion of Wharton's jelly derived mesenchymal stem cells? A comparative study.
Swamynathan P; Venugopal P; Kannan S; Thej C; Kolkundar U; Bhagwat S; Ta M; Majumdar AS; Balasubramanian S
Stem Cell Res Ther; 2014 Jul; 5(4):88. PubMed ID: 25069491
[TBL] [Abstract][Full Text] [Related]
5. Development and characterization of a clinically compliant xeno-free culture medium in good manufacturing practice for human multipotent mesenchymal stem cells.
Chase LG; Yang S; Zachar V; Yang Z; Lakshmipathy U; Bradford J; Boucher SE; Vemuri MC
Stem Cells Transl Med; 2012 Oct; 1(10):750-8. PubMed ID: 23197667
[TBL] [Abstract][Full Text] [Related]
6. Differential Development of Umbilical Cord-Derived Mesenchymal Stem Cells During Long-Term Maintenance in Fetal Bovine Serum-Supplemented Medium and Xeno- and Serum-Free Culture Medium.
Le HM; Nguyen LT; Hoang DH; Bach TQ; Nguyen HTN; Mai HT; Trinh DP; Nguyen TD; Nguyen LT; Than UTT
Cell Reprogram; 2021 Dec; 23(6):359-369. PubMed ID: 34748399
[TBL] [Abstract][Full Text] [Related]
7. Influence of the mesenchymal stromal cell source on the hematopoietic supportive capacity of umbilical cord blood-derived CD34
Bucar S; Branco ADM; Mata MF; Milhano JC; Caramalho Í; Cabral JMS; Fernandes-Platzgummer A; da Silva CL
Stem Cell Res Ther; 2021 Jul; 12(1):399. PubMed ID: 34256848
[TBL] [Abstract][Full Text] [Related]
8. Isolation, expansion and characterization of bone marrow-derived mesenchymal stromal cells in serum-free conditions.
Gottipamula S; Ashwin KM; Muttigi MS; Kannan S; Kolkundkar U; Seetharam RN
Cell Tissue Res; 2014 Apr; 356(1):123-35. PubMed ID: 24448665
[TBL] [Abstract][Full Text] [Related]
9. The effect of culture media on large-scale expansion and characteristic of adipose tissue-derived mesenchymal stromal cells.
Czapla J; Matuszczak S; Kulik K; Wiśniewska E; Pilny E; Jarosz-Biej M; Smolarczyk R; Sirek T; Zembala MO; Zembala M; Szala S; Cichoń T
Stem Cell Res Ther; 2019 Aug; 10(1):235. PubMed ID: 31383013
[TBL] [Abstract][Full Text] [Related]
10. Canine and Equine Mesenchymal Stem Cells Grown in Serum Free Media Have Altered Immunophenotype.
Clark KC; Kol A; Shahbenderian S; Granick JL; Walker NJ; Borjesson DL
Stem Cell Rev Rep; 2016 Apr; 12(2):245-56. PubMed ID: 26638159
[TBL] [Abstract][Full Text] [Related]
11. A critical appraisal of humanized alternatives to fetal bovine serum for clinical applications of umbilical cord derived mesenchymal stromal cells.
Rallapalli S; Guhathakurta S; Bishi DK; Subbarayan R; Mathapati S; Korrapati PS
Biotechnol Lett; 2021 Oct; 43(10):2067-2083. PubMed ID: 34499291
[TBL] [Abstract][Full Text] [Related]
12. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow.
Bieback K; Hecker A; Kocaömer A; Lannert H; Schallmoser K; Strunk D; Klüter H
Stem Cells; 2009 Sep; 27(9):2331-41. PubMed ID: 19544413
[TBL] [Abstract][Full Text] [Related]
13. Large-scale expansion of pre-isolated bone marrow mesenchymal stromal cells in serum-free conditions.
Gottipamula S; Muttigi MS; Chaansa S; Ashwin KM; Priya N; Kolkundkar U; SundarRaj S; Majumdar AS; Seetharam RN
J Tissue Eng Regen Med; 2016 Feb; 10(2):108-19. PubMed ID: 23495227
[TBL] [Abstract][Full Text] [Related]
14. Standardized xeno- and serum-free culture platform enables large-scale expansion of high-quality mesenchymal stem/stromal cells from perinatal and adult tissue sources.
Hoang VT; Trinh QM; Phuong DTM; Bui HTH; Hang LM; Ngan NTH; Anh NTT; Nhi PY; Nhung TTH; Lien HT; Nguyen TD; Thanh LN; Hoang DM
Cytotherapy; 2021 Jan; 23(1):88-99. PubMed ID: 33097415
[TBL] [Abstract][Full Text] [Related]
15. Optimization of human mesenchymal stem cell manufacturing: the effects of animal/xeno-free media.
Oikonomopoulos A; van Deen WK; Manansala AR; Lacey PN; Tomakili TA; Ziman A; Hommes DW
Sci Rep; 2015 Nov; 5():16570. PubMed ID: 26564250
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of the biological characteristics of serum-free and fetal bovine serum-contained medium cultured umbilical cord-derived mesenchymal stem cells].
Yang T; Chen GH; Xue SL; Qiao M; Liu HW; Tian H; Qiao SM; Chen F; Chen ZZ; Sun AN; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2012 Sep; 33(9):715-9. PubMed ID: 23336223
[TBL] [Abstract][Full Text] [Related]
17. Production and Administration of Therapeutic Mesenchymal Stem/Stromal Cell (MSC) Spheroids Primed in 3-D Cultures Under Xeno-free Conditions.
Ylostalo JH; Bazhanov N; Mohammadipoor A; Bartosh TJ
J Vis Exp; 2017 Mar; (121):. PubMed ID: 28362380
[TBL] [Abstract][Full Text] [Related]
18. Optimization of human umbilical cord blood-derived mesenchymal stem cell isolation and culture methods in serum- and xeno-free conditions.
Nguyen LT; Tran NT; Than UTT; Nguyen MQ; Tran AM; Do PTX; Chu TT; Nguyen TD; Bui AV; Ngo TA; Hoang VT; Hoang NTM
Stem Cell Res Ther; 2022 Jan; 13(1):15. PubMed ID: 35012671
[TBL] [Abstract][Full Text] [Related]
19. Development of fully defined xeno-free culture system for the preparation and propagation of cell therapy-compliant human adipose stem cells.
Patrikoski M; Juntunen M; Boucher S; Campbell A; Vemuri MC; Mannerström B; Miettinen S
Stem Cell Res Ther; 2013 Mar; 4(2):27. PubMed ID: 23497764
[TBL] [Abstract][Full Text] [Related]
20. Isolation and prolonged expansion of oral mesenchymal stem cells under clinical-grade, GMP-compliant conditions differentially affects "stemness" properties.
Bakopoulou A; Apatzidou D; Aggelidou E; Gousopoulou E; Leyhausen G; Volk J; Kritis A; Koidis P; Geurtsen W
Stem Cell Res Ther; 2017 Nov; 8(1):247. PubMed ID: 29096714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
